Fruzaqla

Active Ingredient(s): Fruquintinib
FDA Approved: * November 8, 2023
Pharm Company: * TAKEDA PHARMS USA
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Fruzaqla 1 mg Oral Capsule
NDC: 63020-210
Labeler:
Takeda Pharmaceuticals America, Inc.
Fruzaqla 5 mg Oral Capsule
NDC: 63020-225
Labeler:
Takeda Pharmaceuticals America, Inc.